Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupali Arora

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
The American Journal of Surgical Pathology|September 18, 2015
Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4aRomy van Baars, Heather Griffin, Zhonglin Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 10, 2020
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh, et al.
International Journal of Cancer|July 22, 2009
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle studyMartin Widschwendter, Sophia Apostolidou, Allison A Jones, et al.
The American Journal of Surgical Pathology|April 3, 2026
GLI1-Rearranged Tumors of the gynaecologic Tract: A Detailed Clinicopathologic Study of 10 CasesRoman E Zyla, Brooke E Howitt, Tjalling Bosse, et al.
Oncology|June 4, 2016
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial CancerCharlotte R Lemech, Leah Ensell, Jennifer C Paterson, et al.
International Journal of Cancer|May 13, 2024
High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalitiesOjone Illah, Malcolm Scott, Elisa Redl, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conferenceFarzana Pashankar, Krisztina Hanley, Michelle Lockley, et al.
International Journal of Cancer|December 10, 2024
Performance of the WID-qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in GhanaSebastian Ken-Amoah, Elisa Redl, Bright K S Domson, et al.
Cancers|March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian CarcinogenesisShaun Haran, Kantaraja Chindera, May Sabry, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
The American Journal of Surgical Pathology|September 18, 2015
Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4aRomy van Baars, Heather Griffin, Zhonglin Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 10, 2020
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh, et al.
International Journal of Cancer|July 22, 2009
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle studyMartin Widschwendter, Sophia Apostolidou, Allison A Jones, et al.
The American Journal of Surgical Pathology|April 3, 2026
GLI1-Rearranged Tumors of the gynaecologic Tract: A Detailed Clinicopathologic Study of 10 CasesRoman E Zyla, Brooke E Howitt, Tjalling Bosse, et al.
Oncology|June 4, 2016
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial CancerCharlotte R Lemech, Leah Ensell, Jennifer C Paterson, et al.
International Journal of Cancer|May 13, 2024
High performance of the DNA methylation-based WID-qEC test for detecting uterine cancers independent of sampling modalitiesOjone Illah, Malcolm Scott, Elisa Redl, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conferenceFarzana Pashankar, Krisztina Hanley, Michelle Lockley, et al.
International Journal of Cancer|December 10, 2024
Performance of the WID-qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in GhanaSebastian Ken-Amoah, Elisa Redl, Bright K S Domson, et al.
Cancers|March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian CarcinogenesisShaun Haran, Kantaraja Chindera, May Sabry, et al.
Pageof 4